Lori Goldstein, MD | Authors

Articles

Endocrine Resistance Therapy in Early-Stage Breast Cancer

August 21, 2014

Lori Goldstein, MD, director, The Naomi and Phil Lippincott Breast Evaluation Center, deputy associate director, Clinical Research, Fox Chase Cancer Center, discusses the possibility of using endocrine resistance therapy to treat patients with early stage breast cancer.